The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. - Mukhopadhyay P; Baggelaar M; Erdelyi K; Cao Z; Cinar R; Fezza F; Ignatowska-Janlowska B; Wilkerson J; van Gils N; Hansen T; Ruben M; Soethoudt M; et al. (British journal of pharmacology, 2016)